Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or“the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news